Bamboos Health Care Holdings Valuation
Is 2293 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2293?
Other financial metrics that can be useful for relative valuation.
| What is 2293's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | HK$304.00m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.1x |
| Enterprise Value/EBITDA | 4.7x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 2293's PE Ratio compare to its peers?
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 18.5x | ||
1947 Meihao Medical Group | 9.8x | n/a | HK$306.0m |
1406 Clarity Medical Group Holding | 44.5x | n/a | HK$485.9m |
1419 Human Health Holdings | 1.3x | n/a | HK$724.9m |
9960 Kindstar Globalgene Technology | 18.5x | 20.2% | HK$1.5b |
2293 Bamboos Health Care Holdings | 5.5x | n/a | HK$304.0m |
Price-To-Earnings vs Peers: 2293 is good value based on its Price-To-Earnings Ratio (5.5x) compared to the peer average (18.5x).
Price to Earnings Ratio vs Industry
How does 2293's PE Ratio compare vs other companies in the HK Healthcare Industry?
Price-To-Earnings vs Industry: 2293 is good value based on its Price-To-Earnings Ratio (5.5x) compared to the Hong Kong Healthcare industry average (11.4x)
Price to Earnings Ratio vs Fair Ratio
What is 2293's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 5.5x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 2293's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 2293 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 2293 (HK$0.76) is trading above our estimate of fair value (HK$0.46)
Significantly Below Fair Value: 2293 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.